Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement in patients with degenerated aortic bioprostheses: Three-year death rates and haemodynamic performance
ViV-TAVR and Re-SAVR had similar mortality and haemodynamic outcomes at 3 years, including in patients with small bioprostheses where self-expandable valves yielded the best results.
Authors
- Patrice Guérin (ORCID: https://orcid.org/0000-0002-8095-8897)
- Thomas Sénage (ORCID: https://orcid.org/0000-0001-8203-0454)
- Gabriel de Rosier
- Guillaume Guimbretière (ORCID: https://orcid.org/0000-0002-5864-0348)
- Jérémie Riou (ORCID: https://orcid.org/0000-0002-7056-9257)
- Loïc Bière (ORCID: https://orcid.org/0000-0002-9321-3739)
- Frédéric Pinaud
- Stéphane Delépine
- Frédéric Rouleau
- Thierry Le Tourneau
- J Roussel
- Claire Bouquin
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Institut du Thorax (FR)
- Université d'Angers (FR)
- Nantes Université (FR)
Publication Details
- Journal
- Archives of cardiovascular diseases
- Published
- 2025-05-24
- DOI
- https://doi.org/10.1016/j.acvd.2025.03.124
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00